174 related articles for article (PubMed ID: 229241)
1. Epstein-Barr virus DNA is amplified in transformed lymphocytes.
Sugden B; Phelps M; Domoradzki J
J Virol; 1979 Sep; 31(3):590-5. PubMed ID: 229241
[TBL] [Abstract][Full Text] [Related]
2. Clonal transformation of adult human leukocytes by Epstein-Barr virus.
Sugden B; Mark W
J Virol; 1977 Sep; 23(3):503-8. PubMed ID: 197258
[TBL] [Abstract][Full Text] [Related]
3. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
Tanaka A; Nonoyama M; Hampar B
Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
[No Abstract] [Full Text] [Related]
4. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.
Sternås L; Middleton T; Sugden B
J Virol; 1990 May; 64(5):2407-10. PubMed ID: 2157896
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
Yajima Y; Nonoyama M
J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
Yajima Y; Tanaka A; Nonoyama M
Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
[No Abstract] [Full Text] [Related]
7. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
Yajima Y; Marczynska B; Nonoyama M
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
[TBL] [Abstract][Full Text] [Related]
8. Replication of latent Epstein-Barr virus genomes in Raji cells.
Adams A
J Virol; 1987 May; 61(5):1743-6. PubMed ID: 3033303
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.
Weigel R; Fischer DK; Heston L; Miller G
J Virol; 1985 Jan; 53(1):254-9. PubMed ID: 2981344
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine.
Hampar B; Lenoir G; Nonoyama M; Derger JG; Chang S
Virology; 1976 Feb; 69(2):660-8. PubMed ID: 176789
[No Abstract] [Full Text] [Related]
11. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells.
Kintner C; Sugden B
J Virol; 1981 Apr; 38(1):305-16. PubMed ID: 6264105
[TBL] [Abstract][Full Text] [Related]
12. P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread.
Miller G; Heston L; Countryman J
J Virol; 1985 Apr; 54(1):45-52. PubMed ID: 2983118
[TBL] [Abstract][Full Text] [Related]
13. Sedimentation characteristics of newly synthesized Epstein-Barr viral DNA in superinfected cells.
Siegel PJ; Clough W; Strominger JL
J Virol; 1981 Jun; 38(3):880-5. PubMed ID: 6264162
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
Summers WC; Klein G
J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
[TBL] [Abstract][Full Text] [Related]
16. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
Bister K; Yamamoto N; zur Hausen H
Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
[TBL] [Abstract][Full Text] [Related]
17. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.
Robinson J
J Virol; 1975 May; 15(5):1065-72. PubMed ID: 167182
[TBL] [Abstract][Full Text] [Related]
18. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.
Sato H; Takimoto T; Tanaka S; Tanaka J; Raab-Traub N
J Virol; 1990 Nov; 64(11):5295-300. PubMed ID: 2170673
[TBL] [Abstract][Full Text] [Related]
19. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
Harrison S; Fisenne K; Hearing J
J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
[TBL] [Abstract][Full Text] [Related]
20. Latent genomes of Epstein-Barr virus.
Tanaka A; Nonoyama M
IARC Sci Publ (1971); 1975; (11 Pt 1):133-7. PubMed ID: 190114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
